The circadian system is an important regulator of immune function. Human inflammatory lung diseases frequently show time-of-day variation in symptom severity and lung function, but the mechanisms and cell types underlying these effects remain unclear. We show that pulmonary antibacterial responses are modulated by a circadian clock within epithelial club (Clara) cells. These drive circadian neutrophil recruitment to the lung via the chemokine CXCL5. Genetic ablation of the clock gene Bmal1 (also called Arntl or MOP3) in bronchiolar cells disrupts rhythmic Cxcl5 expression, resulting in exaggerated inflammatory responses to lipopolysaccharide and an impaired host response to Streptococcus pneumoniae infection. Adrenalectomy blocks rhythmic inflammatory responses and the circadian regulation of CXCL5, suggesting a key role for the adrenal axis in driving CXCL5 expression and pulmonary neutrophil recruitment. Glucocorticoid receptor occupancy at the Cxcl5 locus shows circadian oscillations, but this is disrupted in mice with bronchiole-specific ablation of Bmal1, leading to enhanced CXCL5 expression despite normal corticosteroid secretion. The therapeutic effects of the synthetic glucocorticoid dexamethasone depend on intact clock function in the airway. We now define a regulatory mechanism that links the circadian clock and glucocorticoid hormones to control both time-of-day variation and the magnitude of pulmonary inflammation and responses to bacterial infection. 
Human inflammatory lung diseases, including chronic obstructive pulmonary disease (COPD) and asthma, are responsible for 25% of premature deaths 1 . These conditions frequently show time-of-day variation in symptom severity and lung function, but the mechanisms and cell types that control this are unknown. The recruitment of immune cells to tissues is under circadian control 2, 3 , and several immune cells, including macrophages and mast cells, exhibit robust oscillations of core clock genes and proinflammatory cytokines [4] [5] [6] . Animal studies show that susceptibility to endotoxic shock is clock dependent 5, [7] [8] [9] [10] . Further, the magnitude of response to pathogenic bacterial challenge varies with time of day 11 . The immune response to bacterial infection is partly mediated by neutrophil recruitment to the affected site, which can also cause tissue damage and must therefore be tightly regulated 12 .
Inflammatory responses are inhibited by glucocorticoids, a suppressive mechanism that operates via an indirect 'tethering' action of the ligand-activated glucocorticoid receptor (GR) 13 . Glucocorticoid hormone secretion is clock controlled 14 and acts as a potent circadianentrained stimulus in many peripheral tissues 15 . In addition, the function of the GR is determined by physical interactions with clock component proteins [16] [17] [18] .
It remains unclear how system-wide signals like glucocorticoids integrate with locally operating circadian oscillators to tune responses to environmental insults while avoiding excessive local tissue damage. The lung is uniquely exposed to environmental factors, and disordered amplitude and duration of inflammatory reactions in the lung underpin many lung diseases. We describe here a mechanism linking the circadian clockwork within pulmonary epithelial cells to the action of glucocorticoids in the control of the chemokine CXCL5, which drives circadian inflammatory responses within the lung.
RESULTS

Circadian control of pulmonary inflammation
We assessed pulmonary responses to endotoxin challenge in C57BL/6 mice across the circadian cycle using aerosolized lipopolysaccharide (LPS). Mice were entrained on 12 h/12 h light-dark cycles and housed in darkness for one circadian cycle before study. Animals were then subjected to LPS and killed while maintained in darkness over the subsequent cycle (Aschoff type 2 protocol 19 ). This revealed a threefold variation in inflammatory responses measured in bronchoalveolar lavage (BAL) fluid, with peak infiltration of inflammatory cells, predominantly neutrophils, at circadian time 0 (CT0, dawn; Fig. 1a-c) . Pulmonary macrophage numbers remained low throughout the cycle (Fig. 1d) . Quantification of inflammatory and chemotactic cytokines in BAL fluid revealed circadian rhythmic changes in several cytokines (Fig. 1e) . LPS binds to Toll-like receptor 4 (TLR4),
The observed time-of-day variation in LPS response suggested clock control of pulmonary immunity to bacterial infection. Accordingly, we infected mice at dawn (Zeitgeber time 0, ZT0) and dusk (ZT12) with Streptococcus pneumoniae. At 24 h after ZT12 infection, there was increased pulmonary neutrophilia but no change in lung bacterial burden (Fig. 1f) . By 48h, this early neutrophilia led to significant reductions in lung bacterial burden and dissemination to blood, which suggest a time-of-day mechanism for antibacterial defense in the lung. This apparent phase reversal in timing reflects the wellcharacterized kinetics of pneumococcal infection in mice, with an initial decline in bacteria over 8-12 h after infection followed by bacterial proliferation and tissue invasion 21 .
Previous studies have highlighted the role of the macrophage clock in circadian responses to endotoxin 4, 5 . Bronchoalveolar macrophages from mice expressing a Per2-luciferase fusion gene (Per2-luc mice) 22 exhibited circadian bioluminescent rhythms and clock gene expression ( Supplementary Fig. 2a,b) . Mice lacking the core clock gene Bmal1 within myeloid cells (macrophages and monocytes) and neutrophils (LysM-Bmal1 −/− ; generated by crossing LysM-cre +/− with Bmal1 fl/fl ) 5 showed suppressed expression of clock genes Nr1d1 and Nr1d2 (also known as rev-erbα and rev-erbβ, respectively) in bronchoalveolar macrophages (Supplementary Fig. 2b) . Nonetheless, after administration of aerosolized LPS, they demonstrated amplitude and phasing of neutrophil and cytokine responses similar to those of Bmal1 fl/fl littermate controls (Supplementary Fig. 2c,d and Supplementary Table 1 ), suggesting that cells of monocytic origin are not involved in the circadian gating we observed.
Targeting the circadian clock in pulmonary epithelial cells The nonciliated epithelial cells lining the bronchioles have welldefined roles in pulmonary immune function 23, 24 . Our earlier studies showed that these club cells express clock proteins and are essential for the maintenance of circadian rhythmicity in lung 25 . We crossed Bmal1 fl/fl mice with mice expressing a codon-improved Cre recombinase (iCre) under the control of the club cell secretory protein (CCSP, also known as Scgb1a1) promoter 26 (Fig. 2a) to produce Bmal1 loss in club cells and compared these Bmal1 fl/fl ; Ccsp-icre +/− mice (hereafter called Ccsp-Bmal1 −/− ) with littermate controls carrying Bmal1 fl/fl . In Ccsp-Bmal1 −/− mice, expression of iCre was limited to the lung and trachea (Fig. 2b) .
Using mice expressing the Per2-luc transgene as a background strain, we imaged ectopic lung slices from Ccsp-Bmal1 −/− mice and Bmal1 fl/fl littermate controls 25, 27 (Fig. 2c,d and Supplementary Videos 1 and 2) . This revealed circadian oscillations in PER2 in the bronchioles of Bmal1 fl/fl mice (25.8 ± 0.17 h, mean ± s.e.m., Fig. 2e ) that were disrupted in Ccsp-Bmal1 −/− mice (32.5 ± 0.8 h, Fig. 2f) . Loss of rhythmicity was confined to bronchioles, as clock gene (Bmal1, Nr1d1, Per2 and Cry1) oscillations were similar in both genotypes in the whole lung (Supplementary Fig. 3a) . Gene targeting had no impact on oscillations of clock genes in the liver (Supplementary Fig. 3b ) activating the nuclear factor-κB (NF-κB) pathway and inducing proinflammatory cytokine transcription. Tlr4 is implicated in mediating LPS-induced phase shifts to light 20 . Tlr4 expression showed no variation across the circadian cycle (Supplementary Fig. 1 ), suggesting circadian pulmonary LPS responses are unlikely to involve rhythmic regulation of Tlr4 expression.
npg or behavioral rhythms (Supplementary Fig. 3c ). In situ hybridization revealed expression of Bmal1 and Nr1d1 at CT0 and CT12, respectively, in bronchial epithelia (Fig. 2g,h and Supplementary Fig. 4 ).
As expected, targeted loss of Bmal1 in the bronchioles suppressed expression of its target gene, Nr1d1.
Bronchiolar epithelial cells drive circadian responses
Ccsp-Bmal1 −/− mice exhibited disrupted pulmonary responses to LPS, with a three-to sixfold increase in neutrophilia and overall loss of circadian gating (i.e., the difference in neutrophilia between CT0 and CT12) (Fig. 3a) . This elevated neutrophilia was associated with loss of barrier function as indicated by elevated BAL fluid IgM (Fig. 3b) . Despite increased neutrophil recruitment to the lungs, there was no change in myeloperoxidase activity (Fig. 3c) . Flow cytometry revealed a low-amplitude time-of-day change in neutrophil numbers in naive Bmal1 fl/fl littermate controls, whereas in Ccsp-Bmal1 −/− mice, neutrophil levels were elevated but not altered by time of day ( Supplementary Fig. 5a ). Although these data showed slightly elevated pulmonary neutrophilia under naive conditions, we did not observe marked gross pathological alterations (alveolar volume or ultrastructure) in tissues collected from aged naive mice ( Supplementary Fig. 5b ).
We next quantified a wide range of inflammatory mediators (Supplementary Table 2 ) and found that six mediators were substantially upregulated in Ccsp-Bmal1 −/− mice. We subsequently confirmed that three of these six (Cxcl5, Ccl20 and Ccl8) were significantly different in a repeat cohort of LPS-treated mice ( Fig. 3d and Supplementary Fig. 6a,b) , and CXCL5, as the only neutrophil chemoattractant, emerged as a candidate effector molecule. CXCL5 expression was also in phase with the peak of LPS-induced neutrophilia (Fig. 1e) . LPS-treated Ccsp-Bmal1 −/− mice secreted significantly more (two-to threefold) CXCL5 in BAL fluid compared to Bmal1 fl/fl littermate controls at both CT0 and CT12 (Fig. 3e) , unlike any other cytokine ( Fig. 3e and Supplementary Table 3 ). Neutrophilic inflammation in response to an initial challenge in Ccsp-Bmal1 −/− mice compared to Bmal1 fl/fl mice persisted at a high level and over several days after challenge (Fig. 3f,g ), and it was accompanied by elevated CXCL5 (Fig. 3h) .
We next assessed responses to S. pneumoniae infection. As predicted from the LPS challenge, we saw marked elevation of neutrophil recruitment in Ccsp-Bmal1 −/− mice, probably in response to elevated CXCL5 production (Fig. 3i,j) . However, this augmented neutrophilia occurred without a difference in bacterial CFU recovered from lung or circulation and contrasts with the time-of-day protective effect seen in wild-type animals. This is compatible with earlier observations identifying no commensurate induction in pulmonary myeloperoxidase activity with augmented neutrophilia in response to LPS.
CXCL5 drives pulmonary rhythmic inflammatory responses
Using LPS-stimulated purified mouse bronchial epithelial cells, we observed expression of CXCL5 and CXCL1, but not tumor necrosis factor-α (TNF-α) (Fig. 4a) . CXCL5 acts as a potent neutrophil chemoattractant, as assessed by migratory responses of mouse bone marrow-derived neutrophils (Supplementary Fig. 7 ). Primary human bronchial epithelial cells stimulated with interleukin-1β (IL-1β) also expressed CXCL5 (Fig. 4b) ; in contrast, pulmonary macrophages do not 28 . In situ hybridization demonstrated Cxcl5 expression in naive Bmal1 fl/fl littermate controls that was confined to the bronchioles and elevated at CT0, whereas in Ccsp-Bmal1 −/− mice, expression was elevated at both time points within these tissues (Fig. 4c) . Expression of Cxcl5 mRNA co-localized with CCSP expression within bronchiolar epithelial cells (Supplementary Fig. 8 ). Profiling over 24 h in Bmal1 fl/fl mice revealed that Cxcl5 mRNA expression was rhythmic, peaking in the early light phase, coincident with the elevation in protein (Fig. 4d) . In Ccsp-Bmal1 −/− mice, mRNA expression was nonrhythmic and elevated (fourfold) compared to littermate controls (Fig. 4d) . These elevated baseline CXCL5 levels in naive Ccsp-Bmal1 −/− mice are lung specific, as serum CXCL5 levels showed no time-of-day or genotype difference ( Fig. 4e) . Thus, our results suggest that CCSPexpressing cells are the critical cell type mediating circadian responses to endotoxin challenge.
To determine the role of CXCL5 in conferring clock control to pulmonary innate immunity, we studied global CXCL5-knockout mice. We observed an attenuated dawn (ZT0) neutrophilic response to nebulized LPS compared to wild-type C57BL/6 controls (Fig. 4f) , consistent with our previous results 29 . Together with the observation that there were no significant time-of-day differences in expression of other CXCL chemokines (Fig. 4g) , our findings suggest that CXCL5 regulates pulmonary responses to infection and plays a central role in conferring clock control of inflammation.
Role of glucocorticoids in the rhythmic regulation of CXCL5
The isolated Cxcl5 proximal promoter did not show intrinsic circadian rhythmicity (Supplementary Fig. 9a ) or respond to BMAL1 and CLOCK either alone or together (Supplementary Fig. 9b ), but it was strongly repressed by dexamethasone-activated GR 30 in cells transfected with a GR expression vector (Fig. 5a) . We next explored whether systemic adrenal glucocorticoids activating GR act as a circadian repressor of CXCL5 expression. We assessed circadian variation in pulmonary neutrophilic inflammation in adrenalectomized mice. The circadian rhythm in circulating corticosterone in these mice was suppressed but still detectable (Fig. 5b) , owing to an extra-adrenal source 31 . Adrenalectomy caused loss of rhythmic CXCL5 and pulmonary neutrophilia in response to nebulized LPS but no general increase in lung inflammation (Fig. 5c,d) . In contrast, intraperitoneal injection of LPS to adrenalectomized mice caused a significant increase in circulating IL-6 (Supplementary Fig. 10a) . Measurement of pulmonary Per2, Bmal1 and Nr1d1 expression revealed similar high-amplitude, time-of-day-dependent changes in both adrenalectomized and intact animals, indicating that altered pulmonary responses did not arise as a consequence of internal de-synchronization of the local clock (Supplementary Fig. 10b) .
Genome-wide mapping of GR occupancy in relation to chromatin architecture and target gene transcription has previously revealed binding sites in the proximal CXCL5 promoter that overlap with regions of DNase1 hypersensitivity, indicating enhancers 30 . We identified strong diurnal regulation of GR binding to the Cxcl5 glucocorticoid response element in whole lung of Bmal1 fl/fl mice (Fig. 5e) , with augmented binding coincident with the night-time rise in endogenous corticosterone (Fig. 5b) . In Ccsp-Bmal1 −/− mice, GR recruitment to 
npg
Cxcl5 was reduced and no longer rhythmic (Fig. 5e) . Acetylation of lysine 27 on histone H3 (H3/K27Ac) is a robust epigenetic mark of active enhancers 32, 33 . We measured H3/K27Ac to determine enhancer activity and gauge the consequence of GR recruitment. We found increased H3/K27Ac in targeted mice at both time points, consistent with the constitutive increase in Cxcl5 gene expression (Fig. 5e) . These data are therefore compatible with a model in which disrupted GR-mediated repression leads to upregulation of Cxcl5 mRNA in clock gene-targeted mice.
Extending these observations to a GR-transactivated gene, glutamine synthetase (Glul), we observed diurnal variation in GR binding and gene expression in Bmal1 fl/fl tissue ( Fig. 5f and Supplementary Fig. 11 ). Histone H3 acetylation followed GR recruitment, as predicted, as a marker of enhancer activity (Fig. 5f) . In Ccsp-Bmal1 −/− mice, we saw reduced GR enrichment and reduced H3/K27Ac ( Fig. 5f ) with loss of diurnal Glul expression in bronchioles but not in other lung structures (Supplementary Fig. 11) . Thus, club cell disruption of Bmal1 leads to altered dynamics of GR activity specifically in bronchiolar epithelial cells for both GR-repressed and GR-activated genes. The differences we observed were not attributable to altered expression of GR in the lung (Supplementary Fig. 12a,b) .
Ccsp-Bmal1 −/− mice showed the same diurnal variation in hypothalamic-pituitary-adrenal axis activity, as determined by serum corticosterone, as Bmal1 fl/fl littermate controls (Fig. 6a) . This reveals an impact on GR promoter occupancy, consequent to targeting Bmal1 in club cells, which is independent of rhythmic adrenal activity. To determine whether differences in GR recruitment to cis elements in the lung were solely dependent on circadian variation in Fig. 13 ). LPS treatment induced circadiangated neutrophilic responses, which was reduced by DEX treatment, irrespective of challenge time (Fig. 6b) . Of 15 cytokines exhibiting sensitivity to DEX, 7 were responsive at both time points tested ( Fig. 6c and Supplementary Fig. 14) . In contrast, in Ccsp-Bmal1 −/− mice, suppression of LPS-induced neutrophilia by DEX was lost (Fig. 6d) , and this was associated with failure to suppress CXCL5 (Fig. 6e) .
DISCUSSION
Neutrophilic pulmonary inflammation is a feature of adult respiratory distress syndrome and COPD and is an important common feature of severe steroid-resistant asthma [34] [35] [36] . Little is known of the signals regulating neutrophil trafficking and antibacterial action in the lung. We show that a local pulmonary clock specific to bronchiolar CCSPexpressing cells regulates dynamic changes in response to in vivo bacterial challenge. Furthermore, targeting Bmal1 in these cells leads to an exaggerated but apparently ineffective neutrophilic inflammatory response to bacterial infection. This highlights the importance of the bronchiolar epithelium as part of a cell-specific timing mechanism regulating overall homeostasis of pulmonary immunological responses. Our results show that CXCL5, a club cell-produced neutrophil chemokine, is clock controlled and mediates circadian variation in lung inflammation. In support of this notion, CXCL5-null mice showed a loss of circadian rhythmic responses to LPS. The specific role of CXCL5 is notable, as several members of this chemokine family regulate neutrophil homeostasis (CXCL1, CXCL2, CXCL5 and CXCL15) 29, [37] [38] [39] [40] , but only CXCL5 regulation was circadian. CXCL5 is also associated with several autoimmune diseases, including rheumatoid arthritis, that have circadian phenotypes 41 .
Neutrophils are proposed to use chemokines as initial signals to guide localization but then switch to bacterial-derived signals for final homing 42 . If excess CXCL5 is secreted, this may impair final neutrophil targeting of bacteria and hence killing. However, the augmented neutrophilia is predicted to lead to excessive pulmonary damage. Therefore, our results support a role for the pulmonary circadian clock in tissue homeostasis and responses to infection. Furthermore, aberrant control of neutrophilic lung inflammation, an important feature in COPD, may arise as a consequence of disruption of normal circadian function. In this context, it is notable that cigarette smoke suppresses pulmonary clock gene expression 43, 44 .
CXCL5 is known to be strongly regulated by glucocorticoids 45 , an effect mediated by GR binding to two conserved site cis elements in the proximal promoter region 30 . Our studies, using whole-lung tissue, reveal strong time-of-day changes in GR occupancy on Cxcl5. This may indicate an underlying change in chromatin architecture, resulting in enhancer activation and thereby impaired GR recruitment; alternatively, it may indicate that impaired GR recruitment, due to altered chromatin architecture, results in loss of GR enhancer inhibition (or it could be a combination of both mechanisms). Similarly, analysis of Glul revealed impairment of GR function with less GR recruitment and, on this transactivation target, consequently reduced H3/K27Ac. Taken together, this implies a broader dysregulation of GR function in the Bmal1-disrupted cells. Furthermore, adrenalectomy, which removes endogenous glucocorticoid timing signals, also abolished time-of-day variation in CXCL5 and neutrophil infiltration without de-repressing neutrophilia. Thus, loss of normal circadian 
Concentration (pg/ml BAL) Concentration (pg/ml BAL) 2,500 4,000 ; LPS + DEX, n = 7) and littermate controls (LPS, n = 3; LPS + DEX, n = 6) (Student's t-test; *P ≤ 0.05) (d) and local cytokine and chemokine production in the same study (one-way ANOVA and post hoc Bonferroni) (e). (f) Schematic illustrating how a local bronchiolar clock and circulating rhythmic glucocorticoids regulate the response to timed endotoxin and bacterial challenge. In the normal state, CXCL5 is regulated by interaction of a local circadian bronchiolar clock and systemic repressive glucocorticoid signals of adrenal origin, resulting in clock-regulated responses to endotoxin and bacterial infection (1) . Ablation of Bmal1 in the epithelial club cells leads to disrupted GR signaling, nonrhythmic expression of CXCL5 and neutrophilia, despite a persistent glucocorticoid rhythm (2) . In this state, neutrophil chemotaxis may be impaired, leading to reduced efficiency of bacterial clearance. In adrenalectomized mice, loss of the rhythmic repressive adrenal signal leads to loss of circadian gating of CXCL5 and an increased neutrophilic response to endotoxin (3) . Data are expressed as mean ± s.e.m. and *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.005. npg GR function in club cells is dominant over a rhythmic corticosteroid signal in the phenotype we observed.
Using systemic DEX administration, which models therapeutic intervention to treat human pulmonary inflammation, we found loss of glucocorticoid responses in Ccsp-Bmal1 −/− mice. This provided further evidence for a local circadian circuit regulating bronchiolar GR function. Our studies were conducted under tightly matched time-controlled conditions, and one possibility not tested is whether glucocorticoid treatment shifted the phase of target cells in addition to the impact on the amplitude of response.
In conclusion, we identify resonance between an oscillating circadian systemic glucocorticoid signal and locally operating circadian control of GR function to confer clock control of pulmonary innate immunity. We define a mechanism that couples the circadian clockwork and bronchiolar GR to pulmonary innate immunity (Fig. 6f) . The bronchiolar club cell, acting through a single neutrophil chemokine, is the final effector pathway. The efficacy of therapeutically administered glucocorticoids depends on intact clock function in the airway. Therefore, human conditions of persisting pulmonary neutrophilic inflammation, which characteristically fail to resolve in response to glucocorticoid therapy (COPD, adult respiratory distress syndrome and glucocorticoid-resistant asthma), may share a common underlying mechanism of clock disruption, either de novo or in response to particular inflammatory signals.
METHODS
Methods and any associated references are available in the online version of the paper.
